Pharmaceutical Executive-12-01-2020

Assessing the Unexpected: The Unintended Consequences of COVID on Therapeutics

December 11, 2020

Features

40

12

How the pandemic’s impact on physicians and patients has spurred fundamental changes and redefined approaches in areas such as adherence and drug formulation and delivery.

Opening Digital Doors: Remote Selling During COVID-19

December 11, 2020

Features

40

12

Adoption of digital by biopharma reps has added an element of flexibility to their engagement strategies, resulting in better communications with HCPs.

The C-Suite’s Frontline Workers in Digital Change

December 11, 2020

Back Page

40

12

How the CIO role has transformed and strengthened against the backdrop of COVID-19.

Diversity of Thought in Action

December 11, 2020

Executive Profile

40

12

Samit Hirawat, chief medical officer at Bristol Myers Squibb, talks about his leading role in BMS’ $300M, five-year plan to expand its efforts in health equity and his career-long commitment to putting patients first.